Global Synthetic Biology Market 2014-2018
The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment.
The analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018.
The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
06. Market Landscape
07. Market Segmentation by Technology
08. Market Segmentation by Product
09. Market Segmentation by Applications
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
19. Key Vendor Analysis
20. Other Reports in this Series
-- Amyris Inc. -- E. I. du Pont de Nemours and Co. -- Thermo Fisher Scientific Inc. -- Synthetic Genomics Inc. -- Algenol Biofuels Inc. -- ATG:biosynthetics GmbH -- Bayer AG -- Bioneer Corp. -- Biosearch Technologies Inc. -- Bristol-Myers Squibb Co. -- CBC Comprehensive Biomarker Center GmbH -- Cobalt Technologies -- Evolva Holdings SA -- Exxon Mobil Corp. -- GeneWorks Pty Ltd. -- Genomatica Inc. -- Gevo Inc. -- Ginkgo Bioworks -- Green Biologics Ltd. -- New England Biolabs Inc. -- OriGene Technologies Inc. -- REG Life Sciences LLC -- Royal DSM -- Synthorx Inc.
For more information visit http://www.researchandmarkets.com/research/dtxhfz/global_synthetic
Media Contact: Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets